These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 31165980

  • 1. The Use of iPSC-Derived Cardiomyocytes and Optical Mapping for Erythromycin Arrhythmogenicity Testing.
    Podgurskaya AD, Tsvelaya VA, Slotvitsky MM, Dementyeva EV, Valetdinova KR, Agladze KI.
    Cardiovasc Toxicol; 2019 Dec; 19(6):518-528. PubMed ID: 31165980
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The influence of hERG1a and hERG1b isoforms on drug safety screening in iPSC-CMs.
    Goversen B, Jonsson MK, van den Heuvel NH, Rijken R, Vos MA, van Veen TA, de Boer TP.
    Prog Biophys Mol Biol; 2019 Dec; 149():86-98. PubMed ID: 30826123
    [Abstract] [Full Text] [Related]

  • 6. Detection of Drug-Induced Torsades de Pointes Arrhythmia Mechanisms Using hiPSC-CM Syncytial Monolayers in a High-Throughput Screening Voltage Sensitive Dye Assay.
    da Rocha AM, Creech J, Thonn E, Mironov S, Herron TJ.
    Toxicol Sci; 2020 Feb 01; 173(2):402-415. PubMed ID: 31764978
    [Abstract] [Full Text] [Related]

  • 7. The Use of Ratiometric Fluorescence Measurements of the Voltage Sensitive Dye Di-4-ANEPPS to Examine Action Potential Characteristics and Drug Effects on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Hortigon-Vinagre MP, Zamora V, Burton FL, Green J, Gintant GA, Smith GL.
    Toxicol Sci; 2016 Dec 01; 154(2):320-331. PubMed ID: 27621282
    [Abstract] [Full Text] [Related]

  • 8. Proarrhythmia Risk Assessment in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Using the Maestro MEA Platform.
    Qu Y, Vargas HM.
    Toxicol Sci; 2015 Sep 01; 147(1):286-95. PubMed ID: 26117837
    [Abstract] [Full Text] [Related]

  • 9. Assessment of Proarrhythmic Potential of Drugs in Optogenetically Paced Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Patel D, Stohlman J, Dang Q, Strauss DG, Blinova K.
    Toxicol Sci; 2019 Jul 01; 170(1):167-179. PubMed ID: 30912807
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CSAHi study: Validation of multi-electrode array systems (MEA60/2100) for prediction of drug-induced proarrhythmia using human iPS cell-derived cardiomyocytes -assessment of inter-facility and cells lot-to-lot-variability.
    Nozaki Y, Honda Y, Watanabe H, Saiki S, Koyabu K, Itoh T, Nagasawa C, Nakamori C, Nakayama C, Iwasaki H, Suzuki S, Washio I, Takahashi E, Miyamoto K, Yamanishi A, Endo H, Shinozaki J, Nogawa H, Kunimatsu T.
    Regul Toxicol Pharmacol; 2016 Jun 01; 77():75-86. PubMed ID: 26884090
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Limited induction of torsade de pointes by terikalant and erythromycin in an in vivo model.
    Farkas A, Coker SJ.
    Eur J Pharmacol; 2002 Aug 02; 449(1-2):143-53. PubMed ID: 12163118
    [Abstract] [Full Text] [Related]

  • 15. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
    Milberg P, Eckardt L, Bruns HJ, Biertz J, Ramtin S, Reinsch N, Fleischer D, Kirchhof P, Fabritz L, Breithardt G, Haverkamp W.
    J Pharmacol Exp Ther; 2002 Oct 02; 303(1):218-25. PubMed ID: 12235254
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Proarrhythmic effects induced by benzethonium chloride and domiphen bromide in vitro and in vivo.
    Long Y, Hou J, Tang F, Lin Z, Huang X, Li W, Chen Y, Li Z, Wu Z.
    Toxicol Appl Pharmacol; 2021 Nov 15; 431():115731. PubMed ID: 34592322
    [Abstract] [Full Text] [Related]

  • 20. Measurement of J-Tpeakc along with QT-Interval Prolongation May Increase the Assay Sensitivity and Specificity for Predicting the Onset of Drug-Induced Torsade de Pointes: Experimental Evidences Based on Proarrhythmia Model Animals.
    Goto A, Hagiwara-Nagasawa M, Kambayashi R, Chiba K, Izumi-Nakaseko H, Naito AT, Kanda Y, Sugiyama A.
    Cardiovasc Toxicol; 2019 Aug 15; 19(4):357-364. PubMed ID: 30712162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.